New data is coming at #IMS26.

At the 23rd International @Myeloma_Society Annual Meeting in Glasgow, Legend Biotech will present data from our CAR-T cell therapy, including long-term, post-authorization and real-world findings.

These insights build on learnings from our clinical program as we continue our focus on advancing scientific innovation and reaching patients globally.

Learn more about the data we’ll be sharing in Glasgow: https://bit.ly/4xITIZj

#LegendBiotech #CellTherapy #ClinicalResearch